Pavistel Telmisartan 40 mg
Telmisartan 40mg
Tablet · Prescription medication
Korea Pavis Co., Ltd.
MFDS item code 201805310 · Approved 2018.12.27
This product's status changed to Expired on 2023.12.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension and reduction of the risk of cardiovascular events (prevention of myocardial infarction, stroke, etc.)
This medication helps effectively manage blood pressure in patients with essential hypertension. It can be safely taken even in cases where ACE inhibitors are not tolerated. Additionally, it is used to reduce the risk of myocardial infarction, stroke, and death due to cardiovascular diseases in high-risk patients aged 55 or older with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, as well as in high-risk diabetic patients. This medication is effective in preventing serious complications of cardiovascular diseases and improving cardiovascular health in patients.
1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily. Depending on the patient, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. When this medicine is administered in combination with a thiazide diuretic, such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of this medicine orally once daily. The reduction in the risk of cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be necessary. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn during pregnancy; therefore, if pregnancy is confirmed, it should be discontinued immediately. Women with allergic reactions to this medication, those who are pregnant or breastfeeding, patients with severe liver disease, and those with certain hereditary conditions should not take this medication. Elderly patients or those with hyperkalemia, liver impairment, and patients with heart and kidney diseases should use this medication cautiously and be careful to prevent blood pressure from dropping too low. During treatment, blood pressure, kidney function, and serum potassium levels should be regularly monitored to check for any abnormalities. While this medication lowers blood pressure, side effects such as dizziness, headache, dyspepsia, and skin rash may sometimes occur; if symptoms are severe, consultation with a physician is needed. If symptoms of angioedema, such as swelling of the face, lips, or tongue occur, the medication should be stopped immediately and healthcare personnel should be notified. Severe hypotension, renal failure, liver dysfunction, and shock may occur, so if these symptoms are suspected, immediate treatment is required. When taking this medication in conjunction with other antihypertensive drugs, diuretics, or potassium supplements, the risk of side effects may increase due to interactions, so it is essential to consult a doctor or pharmacist. Women planning to become pregnant or who may be pregnant should consult with healthcare providers before taking this medication and should avoid using it during pregnancy. During breastfeeding, this medication is also not recommended; if it must be taken, it is advisable to discontinue breastfeeding. This medication is not recommended for children under 18 years as its safety and efficacy have not been established. In cases of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, requiring immediate medical attention. This medication should be stored out of reach of children and should not be transferred to other containers. Dizziness or drowsiness may occur while driving or operating hazardous machinery, so caution is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage helps to preserve the efficacy of the medication for a longer time.
White oval tablet
30 tablets/box [10 tablets/Alu-Alu*3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Telmisartan 40mg
Tablet · Prescription medication
Korea Pavis Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.